Nutra Pharma delays third-quarter report as financial preparation requires more time
NPHC•Nutra Pharma delayed its Form 10-Q for the quarter ended September 30, 2026, and expects to file within five calendar days of the deadline. It said no significant change in operating results is anticipated from the prior-year period.
1. Filing delay
Nutra Pharma delayed its Form 10-Q for the quarter ended September 30, 2026, in a November 16 notification. Management and auditors need more time to prepare the financial information, and the company expects to file within five calendar days of the prescribed deadline. It said no significant change in operating results is anticipated compared with the corresponding prior-year period.




